Shiga-toxin producing Escherichia coli and the hemolytic uremic syndrome: What have we learned in the past 25 years?

Advances in Experimental Medicine and Biology

Volumn 634, Issue , 2009, Pages 1-17

  Ahn, Christina K ^a   Holt, Nicholas J ^a   Tarr, Phillip I ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; NARCOTIC ANALGESIC AGENT; PARACETAMOL;

BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM DETECTION; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE COURSE; EPIDEMIC; ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI O157; FECES ANALYSIS; FLUID THERAPY; HEMOLYTIC UREMIC SYNDROME; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RATE; PAIN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; RISK REDUCTION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; THROMBOCYTE TRANSFUSION; URBAN RURAL DIFFERENCE;

ESCHERICHIA COLI;

EID: 84934444580     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-79838-7_1     Document Type: Review

References (71)

1. Ackers, M. L., Mahon, B. E., Leahy, E., Goode, B., Damrow, T., Hayes, P. S., Bibb, W. F., Rice, D. H., Barrett, T. J., Hutwagner, L., Griffin, P. M. and Slutsker, L. (1998). An outbreak of Escherichia coli O157:H7 infections associated with leaf lettuce consumption. J Infect Dis 177(6):1588-93. (Pubitemid 28243583)
2. Ahn, C. K., Klein, E. and Tarr, P. I. (2008). Isolation of patients acutely infected with Escherichia coli O157:H7: low-tech, highly effective prevention of hemolytic uremic syndrome. Clin Infect Dis 46(8):1197-9. (Pubitemid 351589902)
3. Ake, J. A., Jelacic, S., Ciol, M. A., Watkins, S. L., Murray, K. F., Christie, D. L., Klein, E. J. and Tarr, P. I. (2005). Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Pediatrics 115(6):e673-80. (Pubitemid 43852790)
4. Bell, B. P., Goldoft, M., Griffin, P. M., Davis, M. A., Gordon, D. C., Tarr, P. I., Bartleson, C. A., Lewis, J. H., Barrett, T. J., Wells, J. G. and et al. (1994). A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA 272(17):1349-53.
5. Bell, B. P., Griffin, P. M., Lozano, P., Christie, D. L., Kobayashi, J. M. and Tarr, P. I. (1997). Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 100(1):E12.
6. Bellomo, R., Kellum, J. A. and Bagshaw, S. M. (2007). Normotensive ischemic acute renal failure. N Engl J Med 357(21):2205; author reply 2205-6. (Pubitemid 350146131)
7. Besser, R. E., Lett, S. M., Weber, J. T., Doyle, M. P., Barrett, T. J., Wells, J. G. and Griffin, P. M. (1993). An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 269(17):2217-20. (Pubitemid 23120276)
8. Bielaszewska, M., Kock, R., Friedrich, A. W., von Eiff, C., Zimmerhackl, L. B., Karch, H. and Mellmann, A. (2007). Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm? PLoS ONE 2(10):e1024.
9. Boyd, B. and Lingwood, C. (1989). Verotoxin receptor glycolipid in human renal tissue. Nephron 51(2):207-10. (Pubitemid 19037693)
10. Brandt, J. R., Joseph, M. W., Fouser, L. S., Tarr, P. I., Zelikovic, I., McDonald, R. A., Avner, E. D., McAfee, N. G. and Watkins, S. L. (1998). Cholelithiasis following Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Nephrol 12(3):222-5. (Pubitemid 28204129)
11. Brooks, J. T., Sowers, E. G., Wells, J. G., Greene, K. D., Griffin, P. M., Hoekstra, R. M. and Strockbine, N. A. (2005). Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J Infect Dis 192(8):1422-9. (Pubitemid 41401157)
12. Carroll, K. C., Adamson, K., Korgenski, K., Croft, A., Hankemeier, R., Daly, J. and Park, C. H. (2003). Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli. Eur J Clin Microbiol Infect Dis 22(11):689-92. (Pubitemid 37491624)
13. Chandler, W. L., Jelacic, S., Boster, D. R., Ciol, M. A., Williams, G. D., Watkins, S. L., Igarashi, T. and Tarr, P. I. (2002). Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome. N Engl J Med 346(1):23-32. (Pubitemid 34438916)
14. Cornick, N. A., Jelacic, S., Ciol, M. A. and Tarr, P. I. (2002). Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome. J Infect Dis 186(1):57-63. (Pubitemid 34666914)
15. Crump, J. A., Sulka, A. C., Langer, A. J., Schaben, C., Crielly, A. S., Gage, R., Baysinger, M., Moll, M., Withers, G., Toney, D. M., Hunter, S. B., Hoekstra, R. M., Wong, S. K., Griffin, P. M. and Van Gilder, T. J. (2002). An outbreak of Escherichia coli O157:H7 infections among visitors to a dairy farm. N Engl J Med 347(8):555-60.
16. Cummings, K. C., Mohle-Boetani, J. C., Werner, S. B. and Vugia, D. J. (2002). Populationbased trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 155(10):941-8. (Pubitemid 34517851)
17. Dundas, S., Todd, W. T., Stewart, A. I., Murdoch, P. S., Chaudhuri, A. K. and Hutchinson, S. J. (2001). The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients. Clin Infect Dis 33(7):923-31. (Pubitemid 32907091)
18. Endo, Y., Tsurugi, K., Yutsudo, T., Takeda, Y., Ogasawara, T. and Igarashi, K. (1988). Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171(1-2):45-50. (Pubitemid 18042873)
19. Fey, P. D., Wickert, R. S., Rupp, M. E., Safranek, T. J. and Hinrichs, S. H. (2000). Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska. Emerg Infect Dis 6(5):530-3.
20. Garg, A. X., Suri, R. S., Barrowman, N., Rehman, F., Matsell, D., Rosas-Arellano, M. P., Salvadori, M., Haynes, R. B. and Clark, W. F. (2003). Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA 290(10):1360-70. (Pubitemid 37442634)
21. Gasser C. G. E., Steck A. (1955). Hamolytisch-uramishe syndrome: Bilaterale Ni.
22. Grif, K., Dierich, M. P., Karch, H. and Allerberger, F. (1998). Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur J Clin Microbiol Infect Dis 17(11):761-6. (Pubitemid 29219127)
23. Inward, C. D., Howie, A. J., Fitzpatrick, M. M., Rafaat, F., Milford, D. V. and Taylor, C. M. (1997). Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology. Pediatr Nephrol 11(5):556-9. (Pubitemid 27397083)
24. Jelacic, J. K., Damrow, T., Chen, G. S., Jelacic, S., Bielaszewska, M., Ciol, M., Carvalho, H. M., Melton-Celsa, A. R., O'Brien, A. D. and Tarr, P. I. (2003). Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 188(5):719-29. (Pubitemid 37115185)
25. Jernigan, S. M. and Waldo, F. B. (1994). Racial incidence of hemolytic uremic syndrome. Pediatr Nephrol 8(5):545-7. (Pubitemid 24287863)
26. Kaplan, B. S., Chesney, R. W. and Drummond, K. N. (1975). Hemolytic uremic syndrome in families. N Engl J Med 292(21):1090-3.
27. Karmali, M. A., Steele, B. T., Petric, M. and Lim, C. (1983). Sporadic cases of haemolyticuraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1(8325):619-20. (Pubitemid 13152343)
28. Karpman, D., Hakansson, A., Perez, M. T., Isaksson, C., Carlemalm, E., Caprioli, A. and Svanborg, C. (1998). Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies. Infect Immun 66(2):636-44. (Pubitemid 28074206)
29. Keene, W. E., Hedberg, K., Herriott, D. E., Hancock, D. D., McKay, R. W., Barrett, T. J. and Fleming, D. W. (1997). A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk. J Infect Dis 176(3):815-8. (Pubitemid 27360560)
30. Keene, W. E., McAnulty, J. M., Hoesly, F. C., Williams, L. P., Jr., Hedberg, K., Oxman, G. L., Barrett, T. J., Pfaller, M. A. and Fleming, D. W. (1994). A swimming-associated outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7 and Shigella sonnei. N Engl J Med 331(9):579-84. (Pubitemid 24265700)
31. Keene, W. E., Sazie, E., Kok, J., Rice, D. H., Hancock, D. D., Balan, V. K., Zhao, T. and Doyle, M. P. (1997). An outbreak of Escherichia coli O157:H7 infections traced to jerky made from deer meat. JAMA 277(15):1229-31. (Pubitemid 27172747)
32. Kimmitt, P. T., Harwood, C. R. and Barer, M. R. (1999). Induction of type 2 Shiga toxin synthesis in Escherichia coli O157 by 4-quinolones. Lancet 353(9164):1588-9. (Pubitemid 29219214)
33. Klein, E. J., Stapp, J. R., Clausen, C. R., Boster, D. R., Wells, J. G., Qin, X., Swerdlow, D. L. and Tarr, P. I. (2002). Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study. J Pediatr 141(2):172-7.
34. Lingwood, C. A. (1994). Verotoxin-binding in human renal sections. Nephron 66(1):21-8. (Pubitemid 23355572)
35. Lingwood, C. A. (2003). Shiga toxin receptor glycolipid binding. Pathology and utility. Methods Mol Med 73:165-86.
36. Loirat, C. and Taylor, C. M. (2003). Hemolytic Uremic Syndromes. Pediatric Nephrology. E. D. Avner, W. E. Harmon and P. Niaudet, Lippincott Williams and Wilkins: 887-915.
37. Lopez, E. L., Diaz, M., Grinstein, S., Devoto, S., Mendilaharzu, F., Murray, B. E., Ashkenazi, S., Rubeglio, E., Woloj, M., Vasquez, M. and et al. (1989). Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 160(3):469-75.
38. Manning, S. D., Madera, R. T., Schneider, W., Dietrich, S. E., Khalife, W., Brown, W., Whittam, T. S., Somsel, P. and Rudrik, J. T. (2007). Surveillance for Shiga toxin-producing Escherichia coli, Michigan, 2001-2005. Emerg Infect Dis 13(2):318-21. (Pubitemid 46193183)
39. March, S. B. and Ratnam, S. (1986). Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J Clin Microbiol 23(5):869-72. (Pubitemid 16120609)
40. McNabb, S. J., Jajosky, R. A., Hall-Baker, P. A., Adams, D. A., Sharp, P., Anderson, W. J., Javier, A. J., Jones, G. J., Nitschke, D. A., Worshams, C. A. and Richard, R. A., Jr. (2007). Summary of notifiable diseases - United States, 2005. MMWR Morb Mortal Wkly Rep 54(53):1-92.
41. Michino, H., Araki, K., Minami, S., Takaya, S., Sakai, N., Miyazaki, M., Ono, A. and Yanagawa, H. (1999). Massive outbreak of Escherichia coli O157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 150(8):787-96. (Pubitemid 29482831)
42. O'Brien, A. O., Lively, T. A., Chen, M. E., Rothman, S. W. and Formal, S. B. (1983). Escherichia coli O157:H7 strains associated with haemorrhagic colitis in the United States produce a Shigella dysenteriae 1(SHIGA) like cytotoxin. Lancet 1(8326 Pt 1):702. (Pubitemid 13158437)
43. O'Brien, S. J., Adak, G. K. and Gilham, C. (2001). Contact with farming environment as a major risk factor for Shiga toxin (Vero cytotoxin)-producing Escherichia coli O157 infection in humans. Emerg Infect Dis 7(6):1049-51. (Pubitemid 33115793)
44. Ostroff, S. M., Kobayashi, J. M. and Lewis, J. H. (1989). Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance. JAMA 262(3):355-9. (Pubitemid 19182839)
45. Pai, C. H., Ahmed, N., Lior, H., Johnson, W. M., Sims, H. V. and Woods, D. E. (1988). Epidemiology of sporadic diarrhea due to verocytotoxin-producing Escherichia coli: a two-year prospective study. J Infect Dis 157(5):1054-7.
46. Park, C. H., Kim, H. J., Hixon, D. L. and Bubert, A. (2003). Evaluation of the duopath verotoxin test for detection of shiga toxins in cultures of human stools. J Clin Microbiol 41(6):2650-3. (Pubitemid 36712482)
47. Pediatrics, A. A. O. (2006). Isolation Precautions. In: Pickering LK, ed. Red Book: 2006 Report of the Committee on Infectious diseases. Red Book. Elk Grove Village, IL: American Academy of Pediatrics: 154-160.
48. Proulx, F., Seidman, E. G. and Karpman, D. (2001). Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50(2):163-71. (Pubitemid 32701188)
49. Riley, L. W., Remis, R. S., Helgerson, S. D., McGee, H. B., Wells, J. G., Davis, B. R., Hebert, R. J., Olcott, E. S., Johnson, L. M., Hargrett, N. T., Blake, P. A. and Cohen, M. L. (1983). Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308(12):681-5. (Pubitemid 13157770)
50. Ritchie, J. M., Thorpe, C. M., Rogers, A. B. and Waldor, M. K. (2003). Critical roles for stx2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71(12):7129-39. (Pubitemid 37475345)
51. Robinson, L. A., Hurley, R. M., Lingwood, C. and Matsell, D. G. (1995). Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells. Pediatr Nephrol 9(6):700-4. (Pubitemid 26003670)
52. Rowe, P. C., Orrbine, E., Lior, H., Wells, G. A., Yetisir, E., Clulow, M. and McLaine, P. N. (1998). Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center. J Pediatr 132(5):777-82. (Pubitemid 28232926)
53. Safdar, N., Said, A., Gangnon, R. E. and Maki, D. G. (2002). Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis. JAMA 288(8):996-1001. (Pubitemid 34920465)
54. Seto, E. Y., Soller, J. A. and Colford, J. M., Jr. (2007). Strategies to reduce person-to-person transmission during widespread Escherichia coli O157:H7 outbreak. Emerg Infect Dis 13(6):860-6. (Pubitemid 46890129)
55. Siegler, R. L., Milligan, M. K., Burningham, T. H., Christofferson, R. D., Chang, S. Y. and Jorde, L. B. (1991). Long-term outcome and prognostic indicators in the hemolytic-uremic syndrome. J Pediatr 118(2):195-200.
56. Siegler, R. L., Obrig, T. G., Pysher, T. J., Tesh, V. L., Denkers, N. D. and Taylor, F. B. (2003). Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol 18(2):92-6. (Pubitemid 41490292)
57. Slutsker, L., Ries, A. A., Greene, K. D., Wells, J. G., Hutwagner, L. and Griffin, P. M. (1997). Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med 126(7):505-13. (Pubitemid 27143628)
58. Swerdlow, D. L., Woodruff, B. A., Brady, R. C., Griffin, P. M., Tippen, S., Donnell, H. D., Jr., Geldreich, E., Payne, B. J., Meyer, A., Jr., Wells, J. G. and et al. (1992). A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med 117(10):812-9.
59. Taguchi, T., Uchida, H., Kiyokawa, N., Mori, T., Sato, N., Horie, H., Takeda, T. and Fujimoto, J. (1998). Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int 53(6):1681-8. (Pubitemid 28243752)
60. Takeda, T., Dohi, S., Igarashi, T., Yamanaka, T., Yoshiya, K. and Kobayashi, N. (1993). Impairment by verotoxin of tubular function contributes to the renal damage seen in haemolytic uraemic syndrome. J Infect 27(3):339-41. (Pubitemid 23346764)
61. Tarr, P. I. and Hickman, R. O. (1987). Hemolytic uremic syndrome epidemiology: a population-based study in King County, Washington, 1971 to 1980. Pediatrics 80(1):41-5. (Pubitemid 17091734)
62. Tarr, P. I., Gordon, C. A. and Chandler, W. L. (2005). Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365(9464):1073-86. (Pubitemid 40386785)
63. Teel, L. D., Daly, J. A., Jerris, R. C., Maul, D., Svanas, G., O'Brien, A. D. and Park, C. H. (2007). Rapid detection of Shiga toxin-producing Escherichia coli by optical immunoassay. J Clin Microbiol 45(10):3377-80. (Pubitemid 47585664)
64. Terajima, J., Izumiya, H., Tamura, K. and Watanabe, H. (2002). [PulseNet Japan-network system for the utilization of epidemiological information and the results of pulsed-field gel electrophoresis]. Nippon Rinsho 60(6):1070-6.
65. Tilden, J., Jr., Young, W., McNamara, A. M., Custer, C., Boesel, B., Lambert-Fair, M. A., Majkowski, J., Vugia, D., Werner, S. B., Hollingsworth, J. and Morris, J. G., Jr. (1996). A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health 86(8):1142-5. (Pubitemid 26271542)
66. Tsai, H. M., Chandler, W. L., Sarode, R., Hoffman, R., Jelacic, S., Habeeb, R. L., Watkins, S. L., Wong, C. S., Williams, G. D. and Tarr, P. I. (2001). von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7-associated hemolytic uremic syndrome. Pediatr Res 49(5):653-9. (Pubitemid 32390854)
67. Uhlich, G. A., Sinclair, J. R., Warren, N. G., Chmielecki, W. A. and Fratamico, P. (2007). Characterization of Shiga toxin-producing Escherichia coli associated with two multi-state foodborne outbreaks that occurred in 2006. Appl Environ Microbiol.
68. Upadhyaya, K., Barwick, K., Fishaut, M., Kashgarian, M. and Siegel, N. J. (1980). The importance of nonrenal involvement in hemolytic-uremic syndrome. Pediatrics 65(1):115-20. (Pubitemid 10068634)
69. Varma, J. K., Greene, K. D., Reller, M. E., DeLong, S. M., Trottier, J., Nowicki, S. F., DiOrio, M., Koch, E. M., Bannerman, T. L., York, S. T., Lambert-Fair, M. A., Wells, J. G. and Mead, P. S. (2003). An outbreak of Escherichia coli O157 infection following exposure to a contaminated building. JAMA 290(20):2709-12. (Pubitemid 37475599)
70. Werber, D., Mason, B. W., Evans, M. R. and Salmon, R. L. (2008). Preventing household transmission of Shiga toxin-producing Escherichia coli O157 infection-promptly separating siblings might be the key. Clin Infect Dis.
71. Wong, C. S., Jelacic, S., Habeeb, R. L., Watkins, S. L. and Tarr, P. I. (2000). The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 342(26):1930-6. (Pubitemid 30419087)